September 2010 Briefing - HIV & AIDSLast Updated: October 01, 2010.
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for September 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
FDA: Certain Lots of Epogen and Procrit Recalled
MONDAY, Sept. 27 (HealthDay News) -- The U.S. Food and Drug Administration and Amgen have notified health care professionals that certain lots of epoetin alfa (Epogen and Procrit) are being recalled, as product vials may contain extremely thin glass flakes (lamellae) that could result in serious adverse events.
HIV Prevalence 19% Among Men Who Have Sex With Men
FRIDAY, Sept. 24 (HealthDay News) -- The prevalence of HIV among men who have sex with men (MSM) remains high in the United States, and 44 percent of infected MSM do not know they are infected, according to research published in the Sept. 24 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
Gel Not Shown to Reduce HIV-1 Incidence in Women
MONDAY, Sept. 20 (HealthDay News) -- PRO2000 microbicide gel is not efficacious against vaginal HIV-1 transmission, according to research published online Sept. 20 in The Lancet.
Sacrifice Makes Industry Gifts Seem More Acceptable
TUESDAY, Sept. 14 (HealthDay News) -- Residents who are reminded of the sacrifices they made to attain their medical education tend to rate the acceptability of industry-sponsored gifts higher than those who are not reminded, according to research published in the Sept. 15 issue of the Journal of the American Medical Association.
Re-Consent Important Before Secondary Use of Genetic Data
MONDAY, Sept. 13 (HealthDay News) -- Most research participants want to be asked for secondary consent -- referred to as re-consent -- before their existing personal genetic data are added to the federal database of Genotypes and Phenotypes (dbGaP), according to research published in the September issue of the Journal of Empirical Research on Human Research Ethics.
High HIV Rate for Men Having Sex With Men in France
FRIDAY, Sept. 10 (HealthDay News) -- Although overall HIV incidence rates in France declined between 2003 and 2008, the rate was drastically higher among men who have sex with men (MSM) than among other groups, according to research published online Sept. 9 in The Lancet Infectious Diseases.
Annual Medical Liability Costs Surpass $50 Billion
THURSDAY, Sept. 9 (HealthDay News) -- The annual costs of the medical liability system in the United States total more than $50 billion, which accounts for a relatively small but non-trivial portion of total health care spending, according to an article in the September issue of Health Affairs.
Nevirapine Reuse in Children With HIV May Be Safe
WEDNESDAY, Sept. 8 (HealthDay News) -- After achieving viral suppression with protease inhibitor-based therapy, most children infected with HIV at birth despite being given nevirapine may safely be switched back to nevirapine-based therapy without fear of drug resistance, according to a study published in the Sept. 8 issue of the Journal of the American Medical Association.
Urban Clinic Increases HIV Testing Uptake in Adolescents
TUESDAY, Sept. 7 (HealthDay News) -- After the publication of national recommendations for routine HIV testing and the implementation of rapid testing, the rate of HIV testing among adolescents at an urban adolescent primary care clinic substantially increased, according to research published in the September issue of the Archives of Pediatrics & Adolescent Medicine.
|Previous: September 2010 Briefing - Gastroenterology||Next: September 2010 Briefing - Infectious Disease|
Reader comments on this article are listed below. Review our comments policy.